Article
Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm.
mBio - 5 Sept 2017
Podnecky Nicole L, Rhodes Katherine A, Mima Takehiko, Drew Heather R, Chirakul Sunisa, Wuthiekanun Vanaporn, Schupp James M, Sarovich Derek S, Currie Bart J, Keim Paul, Schweizer Herbert P
Abstract excerpt
The trimethoprim and sulfamethoxazole combination, co-trimoxazole, plays a vital role in the treatment of Burkholderia pseudomallei infections. Previous studies demonstrated that the B. pseudomallei BpeEF-OprC efflux pump confers widespread trimethoprim resistance in clinical and environmental isolates, but this is not accompanied by significant resistance to co-trimoxazole. Using the excluded select-agent strain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
